0 Comentários
0 Compartilhamentos
135 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Advances in Biomarker-Based Diagnostics Are Transforming the Calprotectin Testing IndustryThe increasing prevalence of inflammatory bowel disease (IBD), growing demand for non-invasive diagnostic tools, and rising awareness of early gastrointestinal disease detection are driving the growth of the calprotectin testing market. However, the market also faces several challenges. High testing costs, limited reimbursement in certain healthcare systems, variability in test...0 Comentários 0 Compartilhamentos 231 Visualizações 0 Anterior
-
Biomarker-Based Testing Gains Importance Across the Cancer Care JourneyThe cancer biomarkers market is entering a period of strong expansion as rising cancer cases, increasing emphasis on early diagnosis, and growing adoption of personalized treatment continue to reshape oncology care. According to Grand View Research, the market size was valued at USD 26.9 billion in 2025 and is projected to increase from USD 29.9 billion in 2026 to USD 65.3 billion by 2033,...0 Comentários 0 Compartilhamentos 710 Visualizações 0 Anterior
-
Carcinoembryonic Antigen (CEA) Market: Cancer Biomarker Testing, Diagnostic Kits, and Monitoring Applications in OncologyExecutive Summary: The Global Carcinoembryonic Antigen (CEA) Market is a vital segment within the cancer diagnostics and tumor marker industry. CEA is a glycoprotein primarily used as a non-specific serum biomarker to monitor treatment efficacy, detect disease recurrence, and provide prognostic information for several cancers, most notably colorectal cancer (CRC). The market is...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Cystatin C Testing Market Growth Outlook 2034: Advancing Biomarker-Based Kidney AssessmentThe Cystatin C Testing Market is gaining momentum as healthcare providers increasingly seek reliable biomarkers for assessing kidney function and identifying renal impairment at an early stage. Cystatin C is a low-molecular-weight protein that can serve as a biomarker for estimating glomerular filtration rate and evaluating kidney function. Compared with traditional creatinine-based...0 Comentários 0 Compartilhamentos 110 Visualizações 0 Anterior
-
Cystatin C Testing Market: Renal Biomarker Testing and Clinical Diagnostics to 2034The Cystatin C Testing Market is gaining importance as healthcare providers increasingly seek sensitive, reliable biomarkers to evaluate kidney function. Cystatin C is a low-molecular-weight protein produced by cells throughout the body and filtered by the kidneys, making it useful for assessing glomerular filtration. Compared with conventional kidney-function assessments, cystatin C testing...0 Comentários 0 Compartilhamentos 100 Visualizações 0 Anterior
-
Diagnostic Tools: How ELISA Testing Kits Are Enhancing Biomarker DetectionThe ERK ELISA Kits Market is experiencing significant growth as ELISA testing kits continue to enhance biomarker detection and disease research. According to market reports, the global ERK ELISA Kits Market was valued at USD 800 million in 2024 and is projected to reach USD 1,500 million by 2035, exhibiting a CAGR of 5.9% during the forecast period. This steady growth reflects the...0 Comentários 0 Compartilhamentos 195 Visualizações 0 Anterior
-
Exploring Investment Opportunities in the North America Metabolic Biomarker Testing MarketThe North America Metabolic Biomarker Testing market continues to play a significant role in the advancement of precision medicine and diagnostic innovation. The region benefits from strong healthcare infrastructure, increasing investments in clinical research, and growing adoption of advanced diagnostic technologies. Rising awareness regarding early disease detection and personalized treatment...0 Comentários 0 Compartilhamentos 531 Visualizações 0 Anterior
-
Lung Cancer Diagnostics Kit Market – Advancing Early Detection Through Molecular and Biomarker TestingMarket Overview The lung cancer diagnostics kit market is expanding as clinical laboratories increasingly adopt molecular and biomarker-based testing to enable earlier, more precise lung cancer detection and treatment selection. Diagnostic kits spanning liquid biopsy, genetic mutation panels, and protein biomarker assays support both initial diagnosis and ongoing treatment monitoring. The Lung...0 Comentários 0 Compartilhamentos 310 Visualizações 0 Anterior
-
PECAM1 ELISA Kit Market – Endothelial Biomarker Testing Advancing Cardiovascular and Cancer ResearchMarket Overview The PECAM1 ELISA kit market is growing as researchers increasingly rely on platelet endothelial cell adhesion molecule testing to study vascular biology, inflammation, and tumor angiogenesis processes. PECAM1, also known as CD31, serves as an important biomarker for endothelial cell function and vascular integrity, making ELISA-based quantification kits valuable tools across...0 Comentários 0 Compartilhamentos 203 Visualizações 0 Anterior
-
Pharmacodynamic Biomarker Testing Market – Precision Dosing Strategies Advancing Drug DevelopmentMarket Overview The pharmacodynamic biomarker testing market is expanding as pharmaceutical companies increasingly rely on biological response indicators to guide dosing decisions during clinical development. Pharmacodynamic biomarkers help researchers understand how a drug affects its target at the molecular level, enabling more precise dose selection and reducing late-stage trial failures....0 Comentários 0 Compartilhamentos 167 Visualizações 0 Anterior
-
The Expanding Market for Diagnostic Protein Analysis: Focus on Protein Biomarker TestingDiagnostic protein analysis is a rapidly evolving field, playing an increasingly central role in disease diagnosis, prognosis, and treatment monitoring. The ability to detect and measure specific proteins, or biomarkers, offers a window into the molecular mechanisms of disease. The market for diagnostic protein analysis is growing, driven by the need for more precise and personalized...0 Comentários 0 Compartilhamentos 245 Visualizações 0 Anterior
-
Blood-Based Biomarker for Alzheimer's Disease Diagnostics Market Innovations in AI-Assisted DiagnosticsThe global Blood-Based Biomarker For Alzheimer’s Disease Diagnostics Market was valued at USD 169.2 million in 2025 and is projected to grow from USD 194.8 million in 2026 to USD 529.9 million by 2033, registering a CAGR of 17.4% from 2026 to 2033. North America dominated the global market with a 43.0% revenue share in 2025, driven by regulatory approvals, expanding clinical...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Adrenal Cancer Diagnostics Market Size and Revenue Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Adrenal Cancer Diagnostics Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Comentários 0 Compartilhamentos 10K Visualizações 0 Anterior
-
Asia-Pacific Genetic Testing Market Size, Share and Forecast Report to 2029According to the latest report published by Data Bridge Market Research, the Asia-Pacific Genetic Testing Market Asia-Pacific genetic testing market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2022 to 2029 and is expected to reach USD 11,255.30...0 Comentários 0 Compartilhamentos 10K Visualizações 0 Anterior
-
Asia-Pacific Multiplex Assays Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Asia-Pacific Multiplex Assays Market The Asia-Pacific multiplex assays market size was valued at USD 750.50 million in 2024 and is expected to reach USD 1,562.55 million by 2032, at a CAGR of 9.6% during the forecast period Attaining maximum return on investment (ROI) is...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Asia-Pacific Multiplex Assays Market Size, Share and Trends Forecast to 2032According to the latest report published by Data Bridge Market Research, the Asia-Pacific Multiplex Assays Market The Asia-Pacific multiplex assays market size was valued at USD 750.50 million in 2024 and is expected to reach USD 1,562.55 million by 2032, at a CAGR of 9.6% during the forecast period The market research studies of Asia-Pacific Multiplex...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Clinical LC-MS Market to Reach USD 1.69 Billion by 2031 | CAGR 7.4%According to a newly published market research report by 24LifeSciences, global clinical LC-MS market was valued at USD 1.03 billion in 2024 and is projected to reach USD 1.69 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period 2025-2031. Liquid chromatography-mass spectrometry (LC-MS), clinically known as the gold standard for clinical...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Companion Diagnostics Market Could Double as Targeted Therapy Adoption RisesThe companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...0 Comentários 0 Compartilhamentos 45 Visualizações 0 Anterior
-
Esoteric Testing Industry Size and Forecast Analysis to 2032According to the latest report published by Data Bridge Market Research, the Esoteric Testing Market The global esoteric testing market size was valued at USD 20.87 billion in 2024 and is expected to reach USD 52.62 billion by 2032, at a CAGR of 12.25 % during the forecast period The comprehensive Esoteric Testing Market report offers a thorough...0 Comentários 0 Compartilhamentos 12K Visualizações 0 Anterior
-
Europe Multiplex Assays Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Europe Multiplex Assays Market The Europe Multiplex Assays market size was valued at USD 609.3 Million in 2024 and is expected to reach USD 1,202.53 Million by 2032, at a CAGR of 8.87% during the forecast period The market research studies of Europe Multiplex Assays...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Europe Multiplex Assays Market Size, Share and Trends Forecast to 2032According to the latest report published by Data Bridge Market Research, the Europe Multiplex Assays Market The Europe Multiplex Assays market size was valued at USD 609.3 Million in 2024 and is expected to reach USD 1,202.53 Million by 2032, at a CAGR of 8.87% during the forecast period The large scale Europe Multiplex Assays Market report comprises...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
Páginas Impulsionadas
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali